105 related articles for article (PubMed ID: 23053021)
1. Is mTOR involved in the mechanisms of the fast-acting antidepressant effects of AMPA receptor agonists?
Hu Y; Liu X; Shen J
Amino Acids; 2013 Mar; 44(3):1093. PubMed ID: 23053021
[No Abstract] [Full Text] [Related]
2. The involvement of AMPA-ERK1/2-BDNF pathway in the mechanism of new antidepressant action of prokinetic meranzin hydrate.
Xie Y; Huang X; Hu SY; Zhang YJ; Wang Y; Qiu XJ; Ren P; Fan R; Zhang CH; Xie WB; Ji H; He J; Chen X; Xie L; Liu ZQ; Zhou HH
Amino Acids; 2013 Feb; 44(2):413-22. PubMed ID: 22782214
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway.
Pochwat B; Sowa-Kucma M; Kotarska K; Misztak P; Nowak G; Szewczyk B
Psychopharmacology (Berl); 2015 Jan; 232(2):355-67. PubMed ID: 25027582
[TBL] [Abstract][Full Text] [Related]
4. Positive Allosteric Modulation of AMPAR by PF-4778574 Produced Rapid Onset Antidepressant Actions in Mice.
Shen M; Lv D; Li S; Zhang Y; Wang Z; Zhao C; Chen X; Wang C
Cereb Cortex; 2019 Sep; 29(10):4438-4451. PubMed ID: 30566581
[TBL] [Abstract][Full Text] [Related]
5. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests.
Andreasen JT; Gynther M; Rygaard A; Bøgelund T; Nielsen SD; Clausen RP; Mogensen J; Pickering DS
Neurosci Lett; 2013 Jun; 546():6-10. PubMed ID: 23643996
[TBL] [Abstract][Full Text] [Related]
6. A role for AMPA receptors in mood disorders.
Alt A; Nisenbaum ES; Bleakman D; Witkin JM
Biochem Pharmacol; 2006 Apr; 71(9):1273-88. PubMed ID: 16442080
[TBL] [Abstract][Full Text] [Related]
7. Folic acid exerts antidepressant effects by upregulating brain-derived neurotrophic factor and glutamate receptor 1 expression in brain.
Gao L; Liu X; Yu L; Wu J; Xu M; Liu Y
Neuroreport; 2017 Nov; 28(16):1078-1084. PubMed ID: 28906345
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor alpha attenuates the functional expression of AMPA receptors in cortical GABAergic neurons.
Namba H; Nagano T; Iwakura Y; Xiong H; Jourdi H; Takei N; Nawa H
Mol Cell Neurosci; 2006 Apr; 31(4):628-41. PubMed ID: 16443372
[TBL] [Abstract][Full Text] [Related]
9. Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures.
Lepack AE; Bang E; Lee B; Dwyer JM; Duman RS
Neuropharmacology; 2016 Dec; 111():242-252. PubMed ID: 27634096
[TBL] [Abstract][Full Text] [Related]
10. The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity?
Freudenberg F; Celikel T; Reif A
Neurosci Biobehav Rev; 2015 May; 52():193-206. PubMed ID: 25783220
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophic effects of AMPA.
Limatola C
Cerebellum; 2004; 3(1):2-10. PubMed ID: 15072261
[TBL] [Abstract][Full Text] [Related]
12. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.
Nguyen L; Matsumoto RR
Behav Brain Res; 2015 Dec; 295():26-34. PubMed ID: 25804358
[TBL] [Abstract][Full Text] [Related]
13. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.
Wei IH; Chen KT; Tsai MH; Wu CH; Lane HY; Huang CC
J Agric Food Chem; 2017 Dec; 65(49):10792-10803. PubMed ID: 29161812
[TBL] [Abstract][Full Text] [Related]
14. SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.
Jiang B; Wang F; Yang S; Fang P; Deng ZF; Xiao JL; Hu ZL; Chen JG
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522427
[TBL] [Abstract][Full Text] [Related]
15. Methoxetamine produces rapid and sustained antidepressant effects probably via glutamatergic and serotonergic mechanisms.
Botanas CJ; Bryan de la Peña J; Custodio RJ; Joy Dela Peña I; Kim M; Woo T; Kim HJ; Kim HI; Chang Cho M; Lee YS; Cheong JH
Neuropharmacology; 2017 Nov; 126():121-127. PubMed ID: 28867363
[TBL] [Abstract][Full Text] [Related]
16. Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice.
Yu H; Li M; Zhou D; Lv D; Liao Q; Lou Z; Shen M; Wang Z; Li M; Xiao X; Zhang Y; Wang C
Neuropharmacology; 2018 Mar; 131():209-222. PubMed ID: 29274366
[TBL] [Abstract][Full Text] [Related]
17. PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13.
Lu Y; Wang C; Xue Z; Li C; Zhang J; Zhao X; Liu A; Wang Q; Zhou W
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25542689
[TBL] [Abstract][Full Text] [Related]
18. AMPA receptors in the therapeutic management of depression.
Bleakman D; Alt A; Witkin JM
CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):117-26. PubMed ID: 17430149
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of long-term sarcosine treatment in rats with or without chronic unpredictable stress.
Chen KT; Wu CH; Tsai MH; Wu YC; Jou MJ; Huang CC; Wei IH
Behav Brain Res; 2017 Jan; 316():1-10. PubMed ID: 27555541
[TBL] [Abstract][Full Text] [Related]
20. Possible role for interactions between 5-lipoxygenase (5-LOX) and AMPA GluR1 receptors in depression and in antidepressant therapy.
Manev R; Mrazovac D; Manev H
Med Hypotheses; 2007; 69(5):1076-9. PubMed ID: 17449191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
